Current issue
Archive
Online first
About the Journal
Editorial Office
Editorial Board
Publisher
Editorial Policies
Ethical standards and procedures
Abstracting and indexing
Reviewers
Honorary Reviewers
Subscription
Contact
Most read articles
Instructions for authors
Article processing charge (APC)
Books and Events
Books
Events
REVIEW PAPER
The devilish power of devil’s claw
Online publication date: 2010-05-14
Reumatologia 2010;48(2):128-132
KEYWORDS
ABSTRACT
Natives in the steppes of South and Southwest Africa use extract of Harpagophytum procumbens for the treatment of various diseases. Various preparations from devil’s claw have been used in Europe and have become very popular in recent years in the alternative treatment of inflammatory disorders of the musculoskeletal system. Extracts of Harpagophytum procumbens have become an established traditional treatment for rheumatic complaints. There is good in vitro and in vivo pharmacological evidence of the anti-inflammatory and analgesic properties of Radix Harpagophyti. The clinical data on extract of Harpagophytum procumbens seem to be very promising.
REFERENCES (41)
1.
Harpagophytum procumbens (Burch.) DC. ex Meisn. subsp. procumbens and subsp. ransvaalense http.www.planzafrica.com/planthij/harpago.htm (18.03.2010). .
2.
Horoszkiewicz-Hassan M. Hakorośl rozesłana (czarci pazur) optymalizacja leczenia chorób zwyrodnieniowych i bólów stawowych lekiem roślinnym – przegląd badań farmakologicznych i klinicznych. Farm Pol 2003; 59: 487-491. .
3.
Kucharski W. Próba wprowadzenia międzynarodowej kontroli nad pozyskiwaniem i handlem Harpagophytum procumbens. Wiad Zielar 2000; 42: 5. .
4.
Lamer-Zarawska E. Lecznicze właściwości Harpagophytum procumbens. Wiad Zielar 2000; 42: 4. .
5.
Denner SS. A review of the efficacy and safety of devil's claw for pain associated with degenerative musculoskeletal diseases, rheumatoid, and osteoarthritis. Holist Nurs Pract 2007; 21: 203-207. .
6.
Harpagophytum procumbens (Devil’s Claw) – monograph. Alternative Medicine Review 2008; 3: 248-252. .
8.
Różański H. Fitoterapia chorób autoimmunologicznych http://luskiewnik.pl/autoimmun... (18.03.2010). .
9.
Boje K, Lechtenberg M, Nahrstedt A. New and known iridoid- and phenylethanoid glycosides from Harpagophytum procumbens and their in vitro inhibition of human leukocyte elastase. Planta Med 2003; 69: 820-825. .
10.
Szczepański L, Chudzik D, Mazurek M, Soroka P. Badania skuteczności i tolerancji preparatu Pagosid (wyciąg z korzenia Harpagophytum procumbens) w leczeniu reumatoidalnego zapalenia stawów i choroby zwyrodnieniowej stawów. Reumatologia 2000; 38: 67-73. .
11.
Piechota-Urbańska M, Kołodziejska J, Berner-Strzelczyk A. Zastosowanie wyciągu z czarciego pazura w przeciwzapalnych preparatach aplikowanych na skórę wytworzonych na bazie polimerów kwasu akrylowego. Polimery w Medycynie 2009; 39: 1-17. .
12.
Abdelouahab N, Heard CM. Dermal and transcutaneous delivery of the major glycoside constituents of Harpagophytum procumbens (Devil's Claw) in vitro. Planta Med 2008; 74: 527-531. .
13.
Fiebich BL, Heinrich M, Hiller K-O, Kammerer N. Inhibition of TNF synthesis in LPS-stimulated primary human monocytes by Harpagophytum extract SteiHap 69. Phytomedicine 2001; 8: 28-30. .
14.
Chrubasik S, Fiebich B, Black A, Pollak S. Treating low back pain with an extract of Harpagophytum that inhibits cytokine release. Eur J Anaesthesiol 2002; 19: 209. .
15.
Jang MH, Lim S, Han SM, et al. Harpagophytum procumbens suppresses lipopolysaccharide-stimulated expressions of cyclooxygenase-2 and inducible nitric oxide synthase in fibroblast cell line L929. J Pharmacol Sci 2003; 93: 367-371. .
16.
Huang TH, Tran VH, Duke RK, et al. Harpagosid suppresses lipopolysaccharide-induced iNOS and COX-2 expression through inhibition of NF-kapp activation. J Ethnopharmacol 2006; 104: 149-155. .
17.
Lanhers MC, Fleurentin J, Mortier F, et al. Anti-infammatory and analgesic efects of an aqueous extract of Harpagophytum procumbens. Planta Med 1992; 58: 117-123. .
18.
Ouitas NA, Heard CM. A novel ex vivo skin model for the assessment of the potential transcutaneous anti-inflammatory effect of topically applied Harpagophytum procumbens extract. Int J Pharm 2009; 376: 63-68. .
19.
Chantre P, Cappelaere A, Leblan D, et al. Efficacy and tolerance of Harpagophytum procumbens versus diacerhein in treatment of osteoarthritis. Phytomedicine 2000; 7: 177-183. .
20.
Brien S, Lewith GT, McGregor G. Devil's Claw (Harpagophytum procumbens) as a treatment for osteoarthritis: a review of efficacy and safety. J Altern Complement Med 2006; 12: 981-993. .
21.
Chrubasik S. Devil's claw extract as an example of the effectiveness of herbal analgesics. Orthopade 2004; 33: 804-808. .
22.
Leblan D, Chantre P, Fournié B.Harpagophytum procumbens in the treatment of knee and hip osteoarthritis. Four-month results of a prospective, multicenter, double-blind trial versus diacerhein. Joint Bone Spine 2000; 67: 462-467. .
23.
Whitehouse LW, Znamirowska M, Paul CJ. Devil's Claw (Harpagophytum procumbens): no evidence for anti-inflammatory activity in the treatment of arthritic disease. Can Med Assoc J 1983; 129: 249-251. .
24.
Setty AR, Sigal LH. Herbal medications commonly used in the practice of rheumatology: mechanisms of action, efficacy, and side effects. Semin Arthritis Rheum 2005; 34: 773-784. .
25.
Warnock M, McBean D, Suter A, et al. Effectiveness and safety of Devil's Claw tablets in patients with general rheumatic disorders. Phytother Res 2007; 21: 1228-1233. .
26.
Gagnier JJ, Chrubasik S, Manheimer E. Harpgophytum procumbens for osteoarthritis and low back pain: a systematic review. BMC Complement Altern Med 2004; 4: 13. .
27.
Chrubasik JE, Roufogalis BD, Chrubasik S. Evidence of effectiveness of herbal antiinflammatory drugs in the treatment of painful osteoarthritis and chronic low back pain. Phytother Res 2007; 21: 675-683. .
28.
Baghdikian B, Lanhers MC, Fleurentin J. Modern treatment of osteoarthritis. PlantaMed 1997; 63: 171-174. .
29.
Long L, Soeken K, Emst E. Princeples and Practice of Phytotherapy. Rheumatology 2001; 40: 77-79. .
30.
Schulze-Tanzil G, Hansen C, Shakibaei M. Effect of Harpagophytum procumbens DC extract on matrix metalloproteinases in human chondrocytes in vitro. Arzneimittelforschung 2004; 54: 213-220. .
31.
Chrubasik JE, Lindhorst E, Neumann E, et al. Potential molecular basis of the chondroprotective effect of Harpagophytum procumbens. Phytomedicine 2006; 13: 598-600. .
32.
Bhattacharya A, Bhattacharya S. Antioxidant activity of Harpagophytum procumbens. Br J Phytother 1998; 5: 68. .
33.
Dugas AJ Jr, Castaneda-Acosta J, Bonin GC, et al. Evaluation of the total peroxyl radical-scavenging capacity of favonoids: structure-activity relationships. J Nat Prod 2000; 63: 327-331. .
34.
Betancor-Fernández A, Pérez-Gálvez A, Sies H, Stahl W. Screening pharmaceutical preparations containing extracts of turmeric rhizome, artichoke leaf, devil's claw root and garlic or salmon oil for antioxidant capacity. J Pharm Pharmacol 2003; 55: 981-986. .
35.
Grant L, McBean DE, Fyfe L, Warnock AM. The inhibition of free radical generation by preparations of Harpagophytum procumbens in vitro.Phytother Res 2009; 23: 104-110. .
36.
Kaszkin M, Beck KF, Koch E, et al. Downregulation of iNOS expression in rat mesangial cells by special extracts of Harpagophytum procumbens derives from harpagoside-dependent and independent effects. Phytomedicine 2004; 11: 585-595. .
38.
Wegener T. Pathogenesis and treatment of osteoarthritis. Herbal Gram 2000; 50: 47. .
39.
Strzelecka H, Kowalski J. Encyklopedia zielarstwa i ziołolecznictwa. PWN, Warszawa 2000; 103-104. .
40.
Mahomed IM, Ojewole JA. Analgesic, antiinfammatory and antidiabetic properties of Harpagophytum procumbens DC (Pedaliaceae) secondary root aqueous extract. Phytother Res 2004; 18: 982-989. .
41.
Wegener T, Lüpke NP. Treatment of patients with arthrosis of hip or knee with an aqueous extract of devil's claw (Harpagophytum procumbens DC.). Phytother Res 2003; 17: 1165-1172.
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
| eISSN: | 2084-9834 |
| ISSN: | 0034-6233 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
